Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study

Fig. 2

Decision curve analysis comparing the number of net benefits for detection of significant cancers for a range of risk threshold values and using different approaches (MRI-PSAd using a PSAd threshold of ≥ 0.15). MRI - magnetic resonance imaging, PSAd - PSA density, phi - Prostate Health Index

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us